ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme-Reference-Cited by-同舟云学术

ALK Rearrangement Testing by FISH Analysis in Non–Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme

Published:2014-10 Issue:10 Volume:9 Page:1470-1476
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Marchetti Antonio,Barberis Massimo,Papotti Mauro,Rossi Giulio,Franco Renato,Malatesta Sara,Buttitta Fiamma,Ardizzoni Andrea,Crinò Lucio,Gridelli Cesare,Taddei Gian Luigi,Clemente Claudio,Scagliotti Giorgio,Normanno Nicola,Pinto Carmine

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

2. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

3. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib;Pao;Proc Natl Acad Sci U S A,2004

4. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer;Kwak;N Engl J Med,2010

5. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma;Morris;Science,1994

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimally Invasive Cytopathology and Accurate Diagnosis: Technical Procedures and Ancillary Techniques;In Vivo;2023

2. Impact of Clinical Practice Gaps on the Implementation of Personalized Medicine in Advanced Non–Small-Cell Lung Cancer;JCO Precision Oncology;2022-10

3. The Significance of External Quality Assessment Schemes for Molecular Testing in Clinical Laboratories;Cancers;2022-07-28

4. Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencing;Virchows Archiv;2021-06-25

5. Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys;Virchows Archiv;2020-11-23